CA Stock MarketDetailed Quotes

NSHS Nanosphere Health Sciences Inc

Watchlist
  • 0.035
  • 0.0000.00%
15min DelayTrading Nov 25 09:30 ET
359.63KMarket Cap-1296P/E (TTM)

Nanosphere Health Sciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
334.01%18.25K
137.57%7.98K
20.63%-53.7K
-162.14%-9.86K
31.30%-26.79K
110.63%4.21K
-325.30%-21.25K
-4.61%-67.66K
180.48%15.87K
0.75%-38.99K
Net income from continuing operations
21.87%-61.06K
22.90%-41.29K
19.03%-228.13K
41.24%-54.94K
-17.80%-41.48K
5.99%-78.15K
23.40%-53.56K
20.92%-281.75K
-149.87%-93.5K
89.94%-35.21K
Operating gains losses
368.54%12.5K
7,693.89%29.84K
-163.01%-27.45K
-268.25%-26.86K
-79.91%4.46K
-142.84%-4.66K
92.78%-393
172.74%43.57K
137.66%15.96K
743.51%22.18K
Remuneration paid in stock
--0
--0
-69.74%2.99K
-100.22%-3
-84.88%247
-59.54%1.38K
-60.38%1.36K
-57.63%9.88K
-59.22%1.39K
-52.87%1.63K
Other non cashItems
----
----
----
----
----
----
---20
----
----
----
Change In working capital
-22.39%66.45K
-38.00%19.43K
23.80%198.89K
-21.82%71.94K
136.18%9.98K
192.31%85.63K
-53.18%31.34K
-51.05%160.65K
154.70%92.02K
-109.06%-27.59K
-Change in receivables
2,022.72%29.88K
-108.79%-1.14K
-10.27%-3.62K
-19.95%-1K
-61.64%-514
-13.10%-1.55K
27.39%-546
-417.31%-3.28K
-380.87%-837
-166.53%-318
-Change in payables and accrued expense
-58.05%36.57K
-35.48%20.57K
23.53%202.51K
-21.44%72.94K
136.87%10.5K
205.31%87.18K
-55.09%31.89K
-49.89%163.93K
155.10%92.86K
-109.37%-28.47K
Cash from discontinued investing activities
Operating cash flow
331.95%18.25K
137.53%7.98K
20.63%-53.7K
-162.14%-9.86K
31.30%-26.79K
110.68%4.23K
-325.70%-21.27K
-4.61%-67.66K
180.48%15.87K
0.75%-38.99K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position
-75.81%8.13K
-83.07%9.32K
-57.93%55.01K
-81.29%11.37K
-70.39%26.19K
-73.00%33.6K
-57.93%55.01K
909.86%130.76K
-59.20%60.75K
1,808.72%88.45K
Current changes in cash
331.95%18.25K
137.53%7.98K
20.63%-53.7K
-162.14%-9.86K
31.30%-26.79K
110.68%4.23K
-325.70%-21.27K
-157.46%-67.66K
204.54%15.87K
-129.23%-38.99K
Effect of exchange rate changes
68.25%-3.69K
-6,270.83%-9.17K
198.99%8K
136.14%7.81K
5.98%11.97K
-427.79%-11.63K
89.04%-144
-12,934.92%-8.09K
-631.12%-21.61K
4.13%11.29K
End cash Position
-13.39%22.68K
-75.81%8.13K
-83.07%9.32K
-83.07%9.32K
-81.29%11.37K
-70.39%26.19K
-73.00%33.6K
-57.93%55.01K
-57.93%55.01K
-59.20%60.75K
Free cash from
331.95%18.25K
137.53%7.98K
20.63%-53.7K
-162.14%-9.86K
31.30%-26.79K
110.68%4.23K
-325.70%-21.27K
-4.61%-67.66K
180.48%15.87K
0.75%-38.99K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 334.01%18.25K137.57%7.98K20.63%-53.7K-162.14%-9.86K31.30%-26.79K110.63%4.21K-325.30%-21.25K-4.61%-67.66K180.48%15.87K0.75%-38.99K
Net income from continuing operations 21.87%-61.06K22.90%-41.29K19.03%-228.13K41.24%-54.94K-17.80%-41.48K5.99%-78.15K23.40%-53.56K20.92%-281.75K-149.87%-93.5K89.94%-35.21K
Operating gains losses 368.54%12.5K7,693.89%29.84K-163.01%-27.45K-268.25%-26.86K-79.91%4.46K-142.84%-4.66K92.78%-393172.74%43.57K137.66%15.96K743.51%22.18K
Remuneration paid in stock --0--0-69.74%2.99K-100.22%-3-84.88%247-59.54%1.38K-60.38%1.36K-57.63%9.88K-59.22%1.39K-52.87%1.63K
Other non cashItems ---------------------------20------------
Change In working capital -22.39%66.45K-38.00%19.43K23.80%198.89K-21.82%71.94K136.18%9.98K192.31%85.63K-53.18%31.34K-51.05%160.65K154.70%92.02K-109.06%-27.59K
-Change in receivables 2,022.72%29.88K-108.79%-1.14K-10.27%-3.62K-19.95%-1K-61.64%-514-13.10%-1.55K27.39%-546-417.31%-3.28K-380.87%-837-166.53%-318
-Change in payables and accrued expense -58.05%36.57K-35.48%20.57K23.53%202.51K-21.44%72.94K136.87%10.5K205.31%87.18K-55.09%31.89K-49.89%163.93K155.10%92.86K-109.37%-28.47K
Cash from discontinued investing activities
Operating cash flow 331.95%18.25K137.53%7.98K20.63%-53.7K-162.14%-9.86K31.30%-26.79K110.68%4.23K-325.70%-21.27K-4.61%-67.66K180.48%15.87K0.75%-38.99K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position -75.81%8.13K-83.07%9.32K-57.93%55.01K-81.29%11.37K-70.39%26.19K-73.00%33.6K-57.93%55.01K909.86%130.76K-59.20%60.75K1,808.72%88.45K
Current changes in cash 331.95%18.25K137.53%7.98K20.63%-53.7K-162.14%-9.86K31.30%-26.79K110.68%4.23K-325.70%-21.27K-157.46%-67.66K204.54%15.87K-129.23%-38.99K
Effect of exchange rate changes 68.25%-3.69K-6,270.83%-9.17K198.99%8K136.14%7.81K5.98%11.97K-427.79%-11.63K89.04%-144-12,934.92%-8.09K-631.12%-21.61K4.13%11.29K
End cash Position -13.39%22.68K-75.81%8.13K-83.07%9.32K-83.07%9.32K-81.29%11.37K-70.39%26.19K-73.00%33.6K-57.93%55.01K-57.93%55.01K-59.20%60.75K
Free cash from 331.95%18.25K137.53%7.98K20.63%-53.7K-162.14%-9.86K31.30%-26.79K110.68%4.23K-325.70%-21.27K-4.61%-67.66K180.48%15.87K0.75%-38.99K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data